市場調查報告書
商品編碼
1567813
2030 年亞太地區分子光譜市場預測 - 區域分析 - 按產品、技術和應用Asia Pacific Molecular Spectroscopy Market Forecast to 2030 - Regional Analysis - by Product, Technology, and Application |
2022年亞太分子光譜市值為8.4903億美元,預計2030年將達到12.8151億美元;預計2022年至2030年複合年成長率為5.3%。
核磁共振光譜的使用增加推動亞太地區分子光譜市場
NMR 是一種用於品質控制和研究的分析技術,可透過其分子結構確定樣品的純度。 NMR 是分析化學和綜合物質科學以及闡明大分子結構和動力學的強大工具。核磁共振波譜的優點在於它需要較少的樣品製備,並且是一種無損方法,可以保存所研究的分子。核磁共振波譜已成為尋找有機化合物結構的領先技術之一,並廣泛應用於製藥、生物技術和生物製藥等各個領域。此外,核磁共振波譜也擴大用於生化和生物應用,包括先導化合物檢測、代謝物分析、體內磁振造影波譜和磁振造影。近年來,核磁共振已被大量納入代謝組學。這個快速發展的領域涉及透過研究代謝物來獲取有關疾病的資訊。代謝組學傳統上專注於研究應用,並且在實驗室診斷中非常有用。代謝組學可以提供有關代謝和細胞過程下游產物的有價值的資訊,並提供對特定組織和器官狀態的深入了解。核磁共振波譜已成功量化各種液體中的代謝物濃度,包括尿液、血漿和血清。核磁共振波譜學取得了新的發展,推動了靈敏度和多功能性方面急需的改進,並擴大了應用數量。將先進的核磁共振診斷技術引入第一線醫療保健產業將可能實現對各種疾病的快速且經濟高效的診斷。隨著研究和產業需求的不斷發展,核磁共振波譜仍處於分析技術的前沿,並推動波譜市場的成長。此外,由於保育研究的不斷增加以及政府促進環境研究的有利政策,分子光譜學也得到了顯著的推動。分子光譜通常用作調查和環境研究中的分析工具。因此,市場參與者正在探索用於各種環境研究的創新分子光譜方法。預計這種情況將在預測期內持續下去,並為市場提供成長機會。
亞太地區分子光譜市場概況
亞太地區分子光譜市場分為中國、日本、印度、韓國、澳洲和亞太其他地區。預計中國將在 2022 年佔據最大的市場佔有率,而印度預計將在市場中呈現顯著的成長速度。這是由於中國的生物製藥產業正在經歷巨大轉變,從以學名藥為中心轉變為蓬勃發展的創新中心。此外,推動新藥、高階醫療器材和技術的產業化和應用也是中國市場成長的原因。此外,越來越多的市場參與者專注於亞太地區國家的地理擴張和其他策略,以及不斷增加的研究中心和政府資助推動了分子光譜市場的成長。
亞太地區分子光譜市場收入及 2030 年預測(百萬美元)
亞太地區分子光譜市場區隔
亞太地區分子光譜市場分為產品、技術、應用和國家。
根據產品,亞太分子光譜市場分為儀器和配件。 2022年,儀器儀表領域將佔據更大的市場佔有率。
從技術角度來看,亞太分子光譜市場分為紫外-可見光光譜、紅外光譜、核磁共振光譜、拉曼光譜、近紅外光譜等。紫外-可見光光譜領域在 2022 年佔據最大的市場。
按應用分類,亞太地區分子光譜市場分為學術和研究應用、生物技術應用、製藥應用等。 2022 年,學術和研究應用領域佔據最大的市場佔有率。
依國家/地區分類,亞太地區分子光譜市場分為澳洲、中國、印度、日本、韓國和亞太地區其他地區。 2022年,中國在亞太分子光譜市場佔有率中佔據主導地位。
堀場有限公司;賽默飛世爾科技公司;默克公司; Revvity公司; Ostec 儀器;日本電子有限公司;島津公司;日本分光公司;布魯克公司;安捷倫科技公司;牛津儀器公司;和 Teledyne Princeton Instruments 是亞太分子光譜市場上的一些領先公司。
The Asia Pacific molecular spectroscopy market was valued at US$ 849.03 million in 2022 and is expected to reach US$ 1,281.51 million by 2030; it is estimated to register a CAGR of 5.3% from 2022 to 2030.
Increasing Use of Nuclear Magnetic Resonance Spectroscopy Boosts Asia Pacific Molecular Spectroscopy Market
NMR is an analytical technique used for quality control and research to determine the purity of a sample with its molecular structure. NMR is a powerful tool in terms of analytical chemistry and consolidated matter science, as well as for elucidating the structure and dynamics of macromolecules. The benefits of NMR spectroscopy are that it requires less sample preparation and is a non-destructive method that preserves the molecules being studied. NMR spectroscopy has become one of the leading techniques for finding out the structure of organic compounds and is widely used in various areas such as pharmaceuticals, biotechnology, and biopharmaceuticals. In addition, NMR spectroscopy is increasingly used in biochemical and biological applications, including hit-to-lead detection, metabolite profiling, in vivo magnetic resonance spectroscopy, and magnetic resonance imaging. In recent years, NMR has been heavily incorporated into metabolomics. This rapidly growing field involves the study of metabolites to gain information about diseases. Metabolomics has traditionally focused on research applications and can prove extremely useful in laboratory diagnostics. Metabolomics can provide valuable information about downstream products of metabolic and cellular processes and provide insights into the state of specific tissues and organs. NMR spectroscopy has successfully quantified metabolite concentrations in various fluids, including urine, plasma, and serum. New developments have been made in NMR spectroscopy, driving much-needed improvements in sensitivity and versatility, and expanding the number of applications. Introducing advanced NMR diagnostic techniques to the frontline healthcare industry will likely enable rapid and cost-effective diagnosis of various diseases. As research and industry needs continue to evolve, NMR spectroscopy remains at the forefront of analytical techniques and drives growth in the spectroscopy market. In addition, molecular spectroscopy has propelled significantly due to increasing research in conservation and favorable government policies to promote environmental studies. Molecular spectroscopy is often used as an analytical tool in surveys and environmental studies. Therefore, market participants are exploring innovative molecular spectroscopy methods for various environmental studies. This is expected to continue during the forecast period and provide growth opportunities for the market.
Asia Pacific Molecular Spectroscopy Market Overview
The Asia Pacific molecular spectroscopy market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China is predicted to hold the largest share of the market in 2022, and India is expected to show a significant growth rate in the market. This is due to China's biopharmaceutical industry undergoing a tremendous shift, evolving from a generic-focused to a thriving innovation hub. Additionally, promoting industrialization and the application of novel drugs, high-end medical devices, and techniques are responsible for the market growth in China. Further, the growing number of market players focusing on countries in Asia Pacific for geographical expansion and other strategies and the rising research centers and government funding fuel the molecular spectroscopy market growth.
Asia Pacific Molecular Spectroscopy Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Molecular Spectroscopy Market Segmentation
The Asia Pacific molecular spectroscopy market is segmented into product, technology, application, and country.
Based on product, the Asia Pacific molecular spectroscopy market is bifurcated into instrument and accessories. The instrument segment held a larger market share in 2022.
In terms of technology, the Asia Pacific molecular spectroscopy market is categorized into UV-Visible spectroscopy, infrared spectroscopy, nuclear magnetic resonance spectroscopy, Raman spectroscopy, Near-infrared spectroscopy, and others. The UV-Visible spectroscopy segment held the largest market share in 2022.
By application, the Asia Pacific molecular spectroscopy market is segmented into academic and research applications, biotechnology applications, pharmaceutical applications, and others. The academic and research applications segment held the largest market share in 2022.
Based on country, the Asia Pacific molecular spectroscopy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific molecular spectroscopy market share in 2022.
Horiba Ltd; Thermo Fisher Scientific Inc; Merck KGaA; Revvity Inc; Ostec Instruments; JEOL Ltd; Shimadzu Corp; JASCO Corp; Bruker Corp; Agilent Technologies, Inc.; Oxfords Instruments plc; and Teledyne Princeton Instruments are some of the leading companies operating in the Asia Pacific molecular spectroscopy market.